Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

What's new: Management of venous leg ulcers: Treating venous leg ulcers.

Alavi A, Sibbald RG, Phillips TJ, Miller OF, Margolis DJ, Marston W, Woo K, Romanelli M, Kirsner RS.

J Am Acad Dermatol. 2016 Apr;74(4):643-64; quiz 665-6. doi: 10.1016/j.jaad.2015.03.059. Review.

PMID:
26979355
2.

What's new: Management of venous leg ulcers: Approach to venous leg ulcers.

Alavi A, Sibbald RG, Phillips TJ, Miller OF, Margolis DJ, Marston W, Woo K, Romanelli M, Kirsner RS.

J Am Acad Dermatol. 2016 Apr;74(4):627-40; quiz 641-2. doi: 10.1016/j.jaad.2014.10.048. Review.

PMID:
26979354
3.

PDGFRα and β play critical roles in mediating Foxq1-driven breast cancer stemness and chemoresistance.

Meng F, Speyer CL, Zhang B, Zhao Y, Chen W, Gorski DH, Miller FR, Wu G.

Cancer Res. 2015 Feb 1;75(3):584-93. doi: 10.1158/0008-5472.CAN-13-3029. Epub 2014 Dec 10.

4.

Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer.

Banda M, Speyer CL, Semma SN, Osuala KO, Kounalakis N, Torres Torres KE, Barnard NJ, Kim HJ, Sloane BF, Miller FR, Goydos JS, Gorski DH.

PLoS One. 2014 Jan 3;9(1):e81126. doi: 10.1371/journal.pone.0081126. eCollection 2014.

5.

Exercise dose, exercise adherence, and associated health outcomes in the TIGER study.

Miller FL, O'Connor DP, Herring MP, Sailors MH, Jackson AS, Dishman RK, Bray MS.

Med Sci Sports Exerc. 2014 Jan;46(1):69-75. doi: 10.1249/MSS.0b013e3182a038b9.

6.

Antagonists of anaphase-promoting complex (APC)-2-cell cycle and apoptosis regulatory protein (CARP)-1 interaction are novel regulators of cell growth and apoptosis.

Puliyappadamba VT, Wu W, Bevis D, Zhang L, Polin L, Kilkuskie R, Finley RL Jr, Larsen SD, Levi E, Miller FR, Wali A, Rishi AK.

J Biol Chem. 2011 Nov 4;286(44):38000-17. doi: 10.1074/jbc.M111.222398. Epub 2011 Sep 8.

7.

Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling.

Zhang H, Meng F, Wu S, Kreike B, Sethi S, Chen W, Miller FR, Wu G.

Cancer Res. 2011 Jul 15;71(14):4846-56. doi: 10.1158/0008-5472.CAN-11-0414. Epub 2011 Jul 12.

8.
9.

Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis.

Zhang H, Meng F, Liu G, Zhang B, Zhu J, Wu F, Ethier SP, Miller F, Wu G.

Cancer Res. 2011 Feb 15;71(4):1292-301. doi: 10.1158/0008-5472.CAN-10-2825. Epub 2011 Feb 1.

10.

Genitocrural agminated papules.

Lountzis NI, Hossler EW, Miller OF 3rd.

J Am Acad Dermatol. 2010 Jan;62(1):e1. doi: 10.1016/j.jaad.2009.06.079. Epub 2009 Dec 15. No abstract available.

PMID:
20082883
11.

Suppression of breast xenograft growth and progression in nude mice: implications for the use of orally administered sphingolipids as chemopreventive agents against breast cancer.

Simon KW, Tait L, Miller F, Cao C, Davy KP, LeRoith T, Schmelz EM.

Food Funct. 2010 Oct;1(1):90-8. doi: 10.1039/c0fo00108b. Epub 2010 Sep 23.

PMID:
21776459
12.

Increased production and secretion of HGF alpha-chain and an antagonistic HGF fragment in a human breast cancer progression model.

Wright TG, Singh VK, Li JJ, Foley JH, Miller F, Jia Z, Elliott BE.

Int J Cancer. 2009 Sep 1;125(5):1004-15. doi: 10.1002/ijc.24364.

13.

Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression.

Fu J, Weise AM, Falany JL, Falany CN, Thibodeau BJ, Miller FR, Kocarek TA, Runge-Morris M.

Breast Cancer Res Treat. 2010 Feb;120(1):35-45. doi: 10.1007/s10549-009-0363-8. Epub 2009 Mar 24.

14.

Proteomic and phosphoproteomic alterations in benign, premalignant and tumor human breast epithelial cells and xenograft lesions: biomarkers of progression.

Kim SH, Miller FR, Tait L, Zheng J, Novak RF.

Int J Cancer. 2009 Jun 15;124(12):2813-28. doi: 10.1002/ijc.24278.

15.

Surgical debridement of painful fingertip calcinosis cutis in CREST syndrome.

Saddic N, Miller JJ, Miller OF 3rd, Clarke JT.

Arch Dermatol. 2009 Feb;145(2):212-3. doi: 10.1001/archderm.145.2.212-b. No abstract available.

PMID:
19221282
16.
17.

Genome based cell population heterogeneity promotes tumorigenicity: the evolutionary mechanism of cancer.

Ye CJ, Stevens JB, Liu G, Bremer SW, Jaiswal AS, Ye KJ, Lin MF, Lawrenson L, Lancaster WD, Kurkinen M, Liao JD, Gairola CG, Shekhar MP, Narayan S, Miller FR, Heng HH.

J Cell Physiol. 2009 May;219(2):288-300. doi: 10.1002/jcp.21663.

18.

Increased invasion through basement membrane by CXCL7-transfected breast cells.

Tang Z, Yu M, Miller F, Berk RS, Tromp G, Kosir MA.

Am J Surg. 2008 Nov;196(5):690-6. doi: 10.1016/j.amjsurg.2008.08.001.

PMID:
18954601
19.

Acquired perforating disorder after exposure to calcium chloride in ice-melting salt.

Wilson M, Mowad C, Ferringer T, Miller OF, Elston D.

Dermatitis. 2008 Sep-Oct;19(5):278-80. No abstract available.

PMID:
18845118
20.

Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death.

Shekhar MP, Tait L, Pauley RJ, Wu GS, Santner SJ, Nangia-Makker P, Shekhar V, Nassar H, Visscher DW, Heppner GH, Miller FR.

Cancer Biol Ther. 2008 Nov;7(11):1774-82. Epub 2008 Nov 12.

Supplemental Content

Loading ...
Support Center